189 related articles for article (PubMed ID: 35261217)
1. Evaluation and simplification of risk factors in FIGO 2000 scoring system for gestational trophoblastic neoplasia: a 19-year retrospective analysis.
Weng Y; Liu Y; Benjoed C; Wu X; Tang S; Li X; Xie X; Lu W
J Zhejiang Univ Sci B; 2022 Mar; 23(3):218-229. PubMed ID: 35261217
[TBL] [Abstract][Full Text] [Related]
2. Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.
Eysbouts YK; Ottevanger PB; Massuger LFAG; IntHout J; Short D; Harvey R; Kaur B; Sebire NJ; Sarwar N; Sweep FCGJ; Seckl MJ
Ann Oncol; 2017 Aug; 28(8):1856-1861. PubMed ID: 28459944
[TBL] [Abstract][Full Text] [Related]
3. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
4. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and influence of lung metastasis on patient outcome in gestational trophoblastic neoplasia: A 10-year study at a single institution.
Yu H; Li J; Zhu T; Xue X; Lu X
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():162-166. PubMed ID: 32505789
[TBL] [Abstract][Full Text] [Related]
6. PREDICT-GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?
Parker VL; Winter MC; Tidy JA; Hancock BW; Palmer JE; Sarwar N; Kaur B; McDonald K; Aguiar X; Singh K; Unsworth N; Jabbar I; Pacey AA; Harrison RF; Seckl MJ
Int J Cancer; 2023 Mar; 152(5):986-997. PubMed ID: 36346113
[TBL] [Abstract][Full Text] [Related]
7. PREDICT-GTN 2: Two-factor streamlined models match FIGO performance in gestational trophoblastic neoplasia.
Parker VL; Winter MC; Tidy JA; Palmer JE; Sarwar N; Singh K; Aguiar X; Hancock BW; Pacey AA; Seckl MJ; Harrison RF
Gynecol Oncol; 2024 Jan; 180():152-159. PubMed ID: 38091775
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: A ten-year review of 1420 patients.
Jiang F; Wan XR; Xu T; Feng FZ; Ren T; Yang JJ; Zhao J; Yang T; Xiang Y
Gynecol Oncol; 2018 Jun; 149(3):539-544. PubMed ID: 29653688
[TBL] [Abstract][Full Text] [Related]
9. [Curative effects and influenced factors of primary chemotherapy with single-agent methotrexate on low-risk gestational trophoblastic neoplasia].
Wu XD; Chen LL; Shen T; Chen SS; Chen QQ; Qin JL; Fu YF; Lü WG
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1769-1772. PubMed ID: 28647996
[No Abstract] [Full Text] [Related]
10. Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia.
Singhal S; Kumar L; Kumar S; Khurana S; Bhatla N
Indian J Med Res; 2020 Dec; 152(6):595-606. PubMed ID: 34145099
[TBL] [Abstract][Full Text] [Related]
11. Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia.
Ramírez LAC; Maestá I; Bianconi MI; Jankilevich G; Otero S; Mejía CRV; Cortés-Charry R; Elias KM; Horowitz NS; Seckl M; Berkowitz RS
Rev Bras Ginecol Obstet; 2022 Aug; 44(8):746-754. PubMed ID: 35760362
[TBL] [Abstract][Full Text] [Related]
12. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
13. Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13.
Bolze PA; Riedl C; Massardier J; Lotz JP; You B; Schott AM; Hajri T; Golfier F
Am J Obstet Gynecol; 2016 Mar; 214(3):390.e1-8. PubMed ID: 26433171
[TBL] [Abstract][Full Text] [Related]
14. Management and prognostic analysis of patients with gestational trophoblastic neoplasia (GTN) in FIGO stage IV and its special type.
Wang K; Chen Y
Clin Exp Metastasis; 2021 Feb; 38(1):47-59. PubMed ID: 33219408
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study.
Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y
Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032
[TBL] [Abstract][Full Text] [Related]
16. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
Oranratanaphan S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for methotrexate resistance in low-risk gestational trophoblastic neoplasia patients (FIGO score 0-4).
Jin T; Zhou Z; Lin M; Yuan S; Xue Y; Yin T; Xu R; Chen B; Zhang J; Sun J; Li X; Hu Y; Chen L; Wang H
Am J Cancer Res; 2024; 14(3):1353-1362. PubMed ID: 38590416
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia.
Maestá I; Growdon WB; Goldstein DP; Bernstein MR; Horowitz NS; Rudge MV; Berkowitz RS
Gynecol Oncol; 2013 Aug; 130(2):312-6. PubMed ID: 23707672
[TBL] [Abstract][Full Text] [Related]
19. The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid.
Taylor F; Grew T; Everard J; Ellis L; Winter MC; Tidy J; Hancock BW; Coleman RE
Eur J Cancer; 2013 Oct; 49(15):3184-90. PubMed ID: 23870384
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
